Astate, so rare and so precious in the treatment of cancer.
“It is mysterious, only exists in minute quantities, but tomorrow this chemical element could help and treat small cancer cells. Clinical trials will start in Nantes. […]
Indeed one isotope of this radioelement is of great interest in medical research: the astate-211. When it disintegrates, it releases a radioactive particle with sufficient energy to destroy the cells it passes through, making it a serious candidate for the elimination of cancerous tumors that today are difficult to treat.
Published this summer in the journal Chemistry- A European Journal, the first results obtained in Nantes allows serious consideration to be given to the upcoming use of astate-211 in the clinic. The clinical study will be carried out by the Nantes University Hospital, in collaboration with the French West Cancer Institute, as part of an extensive research program around the Arronax cyclotron and the Nantes-Angers Cancer Research Center.